Search

Your search keyword '"Francesco Vizzutti"' showing total 92 results

Search Constraints

Start Over You searched for: Author "Francesco Vizzutti" Remove constraint Author: "Francesco Vizzutti"
92 results on '"Francesco Vizzutti"'

Search Results

1. Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: A long-term follow-up study

2. Alcohol use disorder and liver transplant: new perspectives and critical issues

3. Super-Resolution Microscopy Reveals an Altered Fibrin Network in Cirrhosis: The Key Role of Oxidative Stress in Fibrinogen Structural Modifications

4. Paradoxical embolization in TIPS: take a closer look to the heart

5. Glycogenic hepatopathy associated with type 1 diabetes mellitus as a cause of recurrent liver damage

6. Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD)

7. Transjugular intrahepatic Porto-systemic shunt positively influences the composition and metabolic functions of the gut microbiota in cirrhotic patients

8. Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model

10. Portosystemic shunt is an effective treatment for complications of portal hypertension in hepatic myeloid metaplasia and improves nutritional status

11. Reply

12. Alcohol use disorder and liver transplant: new perspectives and critical issues

13. Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes

14. Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control study

15. Altered clot formation and lysis are associated with increased fibrinolytic activity in ascites in patients with advanced cirrhosis

16. Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up study

17. Low molecular weight heparin does not increase bleeding and mortality post-endoscopic variceal band ligation in cirrhotic patients

18. Effective albumin concentration and albumin function improve after long-term albumin therapy in patients with decompensated cirrhosis

19. Characterization of lymphocyte subsets in ascitic fluid and peripheral blood of decompensated cirrhotic patients with chronic hepatitis C and alcoholic liver disease: A pivotal study

20. Consensus conference on TIPS management: Techniques, indications, contraindications

21. The Metabolic Syndrome and Chronic Liver Disease

22. Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis

23. Hepato-systemic gradient of carbon monoxide in cirrhosis

24. Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis

25. Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis

26. Curcumin limits the fibrogenic evolution of experimental steatohepatitis

27. Transient elastography for the assessment of liver fibrosis in patients with chronic viral hepatitis: The missing tool?

28. Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C

29. Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography

30. Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells

31. Acute viral hepatitis increases liver stiffness values measured by transient elastography

32. Portal Hypertension Secondary to Myelofibrosis: A Study of Three Cases

33. Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice

34. Cardiovascular effects of canrenone in patients with preascitic cirrhosis

35. Paradoxical embolization in TIPS: take a closer look to the heart

36. Aggressive gastric carcinoma producing alpha-fetoprotein: a case report and review of the literature

38. n-3 polyunsaturated fatty acids worsen inflammation and fibrosis in experimental nonalcoholic steatohepatitis

39. Acute on chronic liver failure: From pathophysiology to clinical management

40. Reversible factors in portal hypertension

41. Glycogenic hepatopathy associated with type 1 diabetes mellitus as a cause of recurrent liver damage

42. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis

43. Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease

44. Liver failure complicating segmental hepatic ischaemia induced by a PTFE-coated TIPS stent

45. Increased plasma carbon monoxide in patients with viral cirrhosis and hyperdynamic circulation

46. Elastography for the non-invasive assessment of liver disease: limitations and future developments

47. Performance of elf serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease

48. Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells

49. Non invasive diagnosis of portal hypertension in cirrhotic patients

50. Fibrosis and cirrhosis reversibility: clinical features and implications

Catalog

Books, media, physical & digital resources